Poggibonsi

Italy

5 total trials

Filter these 5 trials by phase, condition, sponsor and more.

Open in Search →

A multicenter open-label phase II study of Cemiplimab plus chemotherapy, selected on the basis of baseline cytidine deaminase activity, in a … Pending

2024-517799-40-00 4 Advanced squamous non-small cell lung cancer
NEOadjuvant Abemaciclib and GIredestrant triaL in patients with ER-positive, HER2-negative Early breast cancer Ended recruitment

2023-510153-42-00 4 2024-11-25 ER-positive, HER2-negative Early breast cancer
MILES5 – A randomized phase 2 study comparing immunotherapy with chemotherapy in the treatment of elderly patients with advanced NSCLC Ended recruitment

2024-515326-83-00 4 2018-07-31 patients with advanced NSCLC
Use of circulating tumor dna test to intensify post-operative treatment of patients with resected colon cancer. Halted

2024-515152-20-00 4 2023-03-02 Stage III and high-risk stage II resected colon cancer patients.
Comparison of two strategies that use the same drugs but with inverted sequence for the treatment of patients with metastatic colorectal can … Ended

2024-513296-41-00 4 2020-12-03 Colorectal cancer spread at distance, RAS BRAF wild type pretreatted

Showing 1–5 of 5 trials